CL2015003803A1 - Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. - Google Patents

Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.

Info

Publication number
CL2015003803A1
CL2015003803A1 CL2015003803A CL2015003803A CL2015003803A1 CL 2015003803 A1 CL2015003803 A1 CL 2015003803A1 CL 2015003803 A CL2015003803 A CL 2015003803A CL 2015003803 A CL2015003803 A CL 2015003803A CL 2015003803 A1 CL2015003803 A1 CL 2015003803A1
Authority
CL
Chile
Prior art keywords
lactea
immune response
improve immune
response capacity
osteopontin
Prior art date
Application number
CL2015003803A
Other languages
English (en)
Inventor
Sarah S Comstock
Anne Staudt Kvistgaard
Peter Lagborg Wejse
Sharon Donovan
Marcia H Monaco Siegel
Original Assignee
Arla Foods Amba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods Amba filed Critical Arla Foods Amba
Publication of CL2015003803A1 publication Critical patent/CL2015003803A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

OSTEOPONTINA LACTEA DE MAMIFERO PARA MEJORAR LA CAPACIDAD DE RESPUESTA INMUNITARIA; COMPOSICIÓN NUTRICIONAL QUE LA COMPRENDE; Y VACUNA DE ADMINISTRACIÓN ORAL.
CL2015003803A 2013-07-05 2015-12-31 Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. CL2015003803A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361843185P 2013-07-05 2013-07-05
EP13175267 2013-07-05

Publications (1)

Publication Number Publication Date
CL2015003803A1 true CL2015003803A1 (es) 2016-08-05

Family

ID=48740972

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015003803A CL2015003803A1 (es) 2013-07-05 2015-12-31 Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.

Country Status (18)

Country Link
US (2) US9956283B2 (es)
EP (1) EP3016673B1 (es)
JP (1) JP6509833B2 (es)
KR (1) KR102307002B1 (es)
CN (1) CN105407910B (es)
AU (1) AU2014286123B2 (es)
BR (1) BR112016000067B1 (es)
CA (1) CA2916821C (es)
CL (1) CL2015003803A1 (es)
DK (1) DK3016673T3 (es)
EA (1) EA034654B1 (es)
ES (1) ES2656474T3 (es)
MX (1) MX369925B (es)
NZ (1) NZ715430A (es)
PH (1) PH12015502844A1 (es)
PL (1) PL3016673T3 (es)
PT (1) PT3016673T (es)
WO (1) WO2015001092A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3784268A4 (en) * 2018-04-25 2022-04-27 Health and Happiness (H&H) Hong Kong Limited COMBINATIONS OF OSTEOPONTIN AND 2'-FUCOSYLLACTOSE FOR USE AS MEDICINES
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum
CN113424962A (zh) * 2020-09-21 2021-09-24 黑龙江飞鹤乳业有限公司 提高免疫力的营养组分、含有其的食品或保健品及其用途
CN113475720B (zh) * 2021-06-15 2023-07-25 合生元（广州）健康产品有限公司 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用
MX2024008884A (es) 2022-01-31 2024-07-29 Soc Des Produits Nestle S A Composiciones que comprenden osteopontina (opn).

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056405A1 (en) * 1997-06-10 1998-12-17 Whitehead Institute For Biomedical Research A method of modulating immune response with osteopontin
JP2002512627A (ja) * 1997-06-11 2002-04-23 アコーダ セラピーティックス Ｃｎｓ神経再生組成物及びその使用方法
EP1175223A2 (en) * 1999-04-15 2002-01-30 Children's Medical Center Corporation Methods and compositions for modulating an immune response
US7259243B2 (en) 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
AU2003239589A1 (en) * 2002-05-24 2003-12-12 Schering-Plough Ltd. Eta-1 gene and methods for use
RU2379975C2 (ru) 2003-09-18 2010-01-27 Арла Фудс Амба Добавка в состав для детского питания
ES2444843T3 (es) * 2003-09-18 2014-02-27 Arla Foods Amba Fórmula para lactantes
KR20090123115A (ko) * 2008-05-27 2009-12-02 한국생명공학연구원 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법
EA023367B1 (ru) * 2011-03-03 2016-05-31 Арла Фудс Амба Способ выделения остеопонтина из молочных продуктов питания, содержащих смр
US20150344534A1 (en) * 2011-12-07 2015-12-03 Arla Foods Amba Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Also Published As

Publication number Publication date
CN105407910B (zh) 2019-12-03
CA2916821A1 (en) 2015-01-08
PH12015502844B1 (en) 2016-03-28
CA2916821C (en) 2023-10-03
NZ715430A (en) 2022-01-28
JP6509833B2 (ja) 2019-05-08
EP3016673A1 (en) 2016-05-11
EP3016673B1 (en) 2017-10-25
ES2656474T3 (es) 2018-02-27
PT3016673T (pt) 2018-01-30
EA201690057A1 (ru) 2016-07-29
US9956283B2 (en) 2018-05-01
AU2014286123A1 (en) 2016-01-21
JP2016529217A (ja) 2016-09-23
KR102307002B1 (ko) 2021-10-05
US20180289798A1 (en) 2018-10-11
US10772955B2 (en) 2020-09-15
PH12015502844A1 (en) 2016-03-28
US20160136268A1 (en) 2016-05-19
CN105407910A (zh) 2016-03-16
BR112016000067A2 (es) 2017-09-05
DK3016673T3 (da) 2018-01-29
MX369925B (es) 2019-11-25
PL3016673T3 (pl) 2018-04-30
AU2014286123B2 (en) 2019-02-28
EA034654B1 (ru) 2020-03-03
MX2016000107A (es) 2016-06-07
WO2015001092A1 (en) 2015-01-08
KR20160030960A (ko) 2016-03-21
BR112016000067B1 (pt) 2022-08-30

Similar Documents

Publication Publication Date Title
MD3370770T2 (ro) Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora
CL2016002772A1 (es) Composiciones de insulina de rápida acción
CL2015002562A1 (es) Anticuerpos e inmunoconjugados anti-b7-h4
EP3152616A4 (en) Efficient, dynamic, high contrast lensing with applications to imaging, illumination and projection
BR112017000039A2 (pt) composições agrícolas e aplicações que utilizam óleos essenciais
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
TWD170334S (zh) 垃圾桶之部分
TWD179502S (zh) 相機
RU2016118771A3 (en) Co-crystals and pharmaceutical compositions comprising the same
TWD168670S (zh) 流體匣之部分
TWD179460S (zh) 機車
CL2015003803A1 (es) Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.
TWD169384S (zh) 包裝盒
UY34406A (es) Compuestos y métodos para mejorar la respuesta inmune innata
CU20170018A7 (es) Moduladores de pirrolopiridina de rorc2 sustituidos con metilo y trifluorometilo
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
EP2968546A4 (en) METHODS OF GENERATING BIOACTIVE PEPTIDE CARRIER ANTIBODIES AND COMPOSITIONS COMPRISING THE SAME
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
BR112015027824A2 (pt) composições de vitamina e em pó
PH12015502242A1 (en) Lutein composition suitable for infant food formulations
DK3319980T3 (da) Formuleringer til forbedring af virkningen af hydrofobe lægemidler
FI20136136A (fi) Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö
UA107533U (uk) Застосування вінборону для потенціювання антифлогістичного ефекту ібупрофену
CN302411077S (zh) 食品罐
UA97245U (en) Succinic acid application to strengthen the antihypoxic effect of thiotriazoline and quercetin